celebrate: carboplatin, etoposide, bevacizumab and atezolizumab in extensive-stage sclc
Published 2 years ago • 281 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
0:26
results of celebrate: carboplatin, etoposide, bevacizumab atezolizumab es-sclc
-
1:50
impower133: atezolizumab, carboplatin plus etoposide for sclc
-
0:42
beat-sc: phase iii trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage sclc
-
5:23
atezolizumab carboplatin/etoposide for extensive-stage small cell lung cancer: impower133 update
-
5:10
lu-177 carboplatin, etoposide, and atezolizumab in sclc • dr. aman chauhan
-
2:35
atezolizumab in combination with carboplatin etoposide for heavily treated small cell lung cancer
-
2:35
atezo maintenance therapy improves survival in the impower133 trial of es-sclc
-
3:42
imbrave050: adjuvant atezolizumab with bevacizumab in high-risk hcc
-
2:36
unexpected safety data in treasure: thoracic radiotherapy with atezolizumab in sclc
-
0:32
will atezolizumab and bevacizumab be the new soc in high-risk hcc?
-
4:00
atezolizumab plus chemotherapy in extensive-stage small cell lung cancer
-
6:33
a win for small–cell lung cancer: impower 133
-
1:41
adjuvant atezolizumab in nsclc
-
1:02
impact of [18f]fdg pet/ct-derived metabolic parameters on outcomes in extensive-stage sclc
-
3:11
impower150: atezolizumab, chemotherapy and bevacizumab for nsclc
-
3:53
gelato: carboplatin and atezolizumab in advanced lobular bc
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
1:06
fort 05-beat: comparing 1l atezolizumab vs atezolizumab bevacizumab in pd-l1 high nsclc
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc